Australia markets closed

Orthocell Limited (OCC.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.3950+0.0150 (+3.95%)
At close: 02:29PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 79.54M
Enterprise value 60.68M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)15.69
Price/book (mrq)36.52
Enterprise value/revenue 12.64
Enterprise value/EBITDA -5.02

Trading information

Stock price history

Beta (5Y monthly) 0.10
52-week change 3-7.32%
S&P500 52-week change 321.23%
52-week high 30.4600
52-week low 30.3200
50-day moving average 30.3970
200-day moving average 30.3884

Share statistics

Avg vol (3-month) 3123.73k
Avg vol (10-day) 3189.83k
Shares outstanding 5209.33M
Implied shares outstanding 6209.33M
Float 8156.51M
% held by insiders 124.49%
% held by institutions 12.49%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -154.57%
Operating margin (ttm)-409.58%

Management effectiveness

Return on assets (ttm)-26.69%
Return on equity (ttm)-177.01%

Income statement

Revenue (ttm)4.8M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)66.00%
Gross profit (ttm)N/A
EBITDA -11.51M
Net income avi to common (ttm)-7.42M
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)19.62M
Total cash per share (mrq)0.1
Total debt (mrq)759.89k
Total debt/equity (mrq)34.88%
Current ratio (mrq)4.60
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-6.64M
Levered free cash flow (ttm)-5.02M